Format

Send to

Choose Destination
Nat Immunol. 2014 May;15(5):431-8. doi: 10.1038/ni.2850. Epub 2014 Mar 23.

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Author information

1
1] Cellular Immunity Laboratory, Cancer Immunology Program, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. [2] Department of Immunology, Monash University, Alfred Medical Research and Education Precinct, Prahran, Australia. [3].
2
1] Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia. [2].
3
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
4
Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
5
1] Hematology Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
6
1] Cellular Immunity Laboratory, Cancer Immunology Program, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
7
1] Cellular Immunity Laboratory, Cancer Immunology Program, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. [2] Department of Immunology, Monash University, Alfred Medical Research and Education Precinct, Prahran, Australia. [3] Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia. [4] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. [5] School of Medicine, University of Queensland, Herston, Australia.

Abstract

CD96, CD226 (DNAM-1) and TIGIT belong to an emerging family of receptors that interact with nectin and nectin-like proteins. CD226 activates natural killer (NK) cell-mediated cytotoxicity, whereas TIGIT reportedly counterbalances CD226. In contrast, the role of CD96, which shares the ligand CD155 with CD226 and TIGIT, has remained unclear. In this study we found that CD96 competed with CD226 for CD155 binding and limited NK cell function by direct inhibition. As a result, Cd96(-/-) mice displayed hyperinflammatory responses to the bacterial product lipopolysaccharide (LPS) and resistance to carcinogenesis and experimental lung metastases. Our data provide the first description, to our knowledge, of the ability of CD96 to negatively control cytokine responses by NK cells. Blocking CD96 may have applications in pathologies in which NK cells are important.

PMID:
24658051
DOI:
10.1038/ni.2850
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center